Using blood sample to analyze circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) to provide up-to-date information on ER and HER2 protein expression and genomic alterations that may guide care planning.
Keywords: 3D, Advertising / Marketing, Patient Education, Disease Management, Oncology
© Todd Buck